Ketorolac Tromethamine
Product Images NDC 0338-0076

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 0338-0076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketorolac Tromethamine Structural Formula (Image 01)

Chemical structure of ketorolac tromethamine, showing the molecular formulas C15H13NO3 and C4H11NO3. The image depicts the arrangement of chemical groups in the combined active ingredient form used in the product.*

FDA Label Image

Image 011

A label for Ketorolac Tromethamine 15 mg/mL, manufactured by Baxter Healthcare Corporation. The label includes storage instructions to keep the product at controlled room temperature between 20° to 25°C (68° to 77°F). It displays the NDC number 0338006910, expiration date April 30, 2021, and lot number DR170519. Barcodes and a QR code are also visible on the label.*

FDA Label Image

Ketorolac Representaive Container Label 0338-0069-10 (Image 02)

Label for Ketorolac Tromethamine Injection, USP 15 mg/mL, a 1 mL single dose vial. The label indicates it is for intravenous or intramuscular use and is manufactured for Baxter Healthcare Corporation. The product is made in India and includes NDC 0338-0069-10 and barcode information.*

FDA Label Image

Ketorolac Representaive Container Label 0338-0072-25 (Image 03)

Packaging label for Ketorolac Tromethamine Injection, USP 15 mg/mL by Baxter Healthcare Corporation. The label specifies use for intravenous or intramuscular administration and indicates the packaging contains 10 single-dose vials of 1 mL each. The label includes the NDC number 0338-0069-10.*

FDA Label Image

Ketorolac Representaive Container Label 0338-0076-10 (Image 04)

Label for Ketorolac Tromethamine Injection, USP 15 mg/mL by Baxter Healthcare Corporation. The label indicates the product is for intravenous or intramuscular use, supplied as 10 single-dose vials of 1 mL each. It includes storage instructions, NDC 0338-0069-10, and mentions manufacturing details and barcode.*

FDA Label Image

Image 05

Label for Ketorolac Tromethamine Injection, USP, 30 mg/mL, in a 1 mL single dose vial. The label states it is for intravenous or intramuscular use and is manufactured for Baxter Healthcare Corporation, Deerfield, IL, USA. The product is made in India and features the Baxter logo.*

FDA Label Image

Image 06

Packaging label for Ketorolac Tromethamine Injection, USP 30 mg/mL by Baxter Healthcare Corporation. The label indicates it is for intravenous or intramuscular use and comes in 25 single-dose vials of 1 mL each. The label includes an NDC number and the phrase Rx Only.*

FDA Label Image

Image 07

Label for Ketorolac Tromethamine Injection USP 30 mg/mL, packaged in 25 single-dose vials of 1 mL each, for intravenous or intramuscular use. The label shows the product name, strength, administration routes, and the manufacturer Baxter Healthcare Corporation, Deerfield, IL, USA. The label includes storage instructions and formulation details, with a barcode and lot information.*

FDA Label Image

Image 08

Label for Ketorolac Tromethamine Injection USP 60 mg/2 mL (30 mg/mL) single dose vial. Label indicates intramuscular use only and is manufactured for Baxter Healthcare Corporation, Deerfield, IL, USA. The product is made in India and includes lot and expiration information fields along with a barcode area.*

FDA Label Image

Image 09

Label for Ketorolac Tromethamine Injection, USP, showing strength 30 mg/mL with a total of 60 mg per 2 mL vial. The label indicates the product is for intramuscular use only and contains 10 single-dose vials of 2 mL each. The labeler is Baxter Healthcare Corporation.*

FDA Label Image

Image 10

KETOROLAC TROMETHAMINE Injection, USP 60 mg/2 mL (30 mg/mL) label for single dose vials, packaged 10 x 2 mL. The label indicates usage for intramuscular injection only. Manufactured by Baxter Healthcare Corporation, detailing storage and sterility information, with a barcode and NDC 0338-0076-10.*

FDA Label Image

Image 12

A label for Ketorolac Tromethamine 30 mg/mL by Baxter Healthcare Corporation. It includes the NDC number 0338007225, storage instructions at controlled room temperature 20°C to 25°C (68°F to 77°F), an expiration date of December 31, 2020, lot number T0070119, and a quantity of 72 units. The label also features multiple barcodes and a QR code.*

FDA Label Image

Image 13

The label for Ketorolac Tromethamine injection shows a concentration of 60 mg per 2 mL vial. The label lists storage instructions to keep at 20° to 25°C (68° to 77°F). The labeler is Baxter Healthcare Corporation in the USA. Additional details include an expiration date of January 31, 2021, and a lot number DR05021900 with a quantity of 72 units.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.